JP2000287915A
(ja)
*
|
1999-04-08 |
2000-10-17 |
Machida Endscope Co Ltd |
手術用案内管装置
|
US7192713B1
(en)
|
1999-05-18 |
2007-03-20 |
President And Fellows Of Harvard College |
Stabilized compounds having secondary structure motifs
|
US6843781B2
(en)
*
|
1999-10-14 |
2005-01-18 |
Becton, Dickinson And Company |
Intradermal needle
|
US20020095134A1
(en)
*
|
1999-10-14 |
2002-07-18 |
Pettis Ronald J. |
Method for altering drug pharmacokinetics based on medical delivery platform
|
US8465468B1
(en)
|
2000-06-29 |
2013-06-18 |
Becton, Dickinson And Company |
Intradermal delivery of substances
|
US6494865B1
(en)
*
|
1999-10-14 |
2002-12-17 |
Becton Dickinson And Company |
Intradermal delivery device including a needle assembly
|
US20020193740A1
(en)
|
1999-10-14 |
2002-12-19 |
Alchas Paul G. |
Method of intradermally injecting substances
|
US20020156453A1
(en)
*
|
1999-10-14 |
2002-10-24 |
Pettis Ronald J. |
Method and device for reducing therapeutic dosage
|
US6569143B2
(en)
|
1999-10-14 |
2003-05-27 |
Becton, Dickinson And Company |
Method of intradermally injecting substances
|
US7241275B2
(en)
|
1999-10-14 |
2007-07-10 |
Becton, Dickinson And Company |
Intradermal needle
|
US6569123B2
(en)
|
1999-10-14 |
2003-05-27 |
Becton, Dickinson And Company |
Prefillable intradermal injector
|
US6776776B2
(en)
|
1999-10-14 |
2004-08-17 |
Becton, Dickinson And Company |
Prefillable intradermal delivery device
|
DE19950530A1
(de)
*
|
1999-10-20 |
2001-06-13 |
Frank Neveling |
Spritze zur intrakutanen Injektion
|
US6537242B1
(en)
|
2000-06-06 |
2003-03-25 |
Becton, Dickinson And Company |
Method and apparatus for enhancing penetration of a member for the intradermal sampling or administration of a substance
|
US20040175360A1
(en)
*
|
2000-06-29 |
2004-09-09 |
Pettis Ronald J. |
Method for altering drug pharmacokinetics based on medical delivery platform
|
US20050008683A1
(en)
*
|
2000-06-29 |
2005-01-13 |
Becton Dickinson And Company |
Method for delivering interferons to the intradermal compartment
|
GB0022742D0
(en)
|
2000-09-15 |
2000-11-01 |
Smithkline Beecham Biolog |
Vaccine
|
NL1016207C2
(nl)
*
|
2000-09-15 |
2002-03-18 |
Univ Erasmus |
Samenstel van een naald en een flu´dumtoevoerinrichting, alsmede een naald, een injectiespuit, een werkwijze voor het uitvoeren van een intraneurale punctie, en een werkwijze voor het voor intraneurale toediening voorbereiden van een inbrenginrichting.
|
US20040096463A1
(en)
*
|
2001-02-23 |
2004-05-20 |
Nathalie Garcon |
Novel vaccine
|
CA2438942A1
(en)
*
|
2001-02-23 |
2002-09-26 |
Glaxosmithkline Biologicals S.A. |
Influenza vaccine formulations for intradermal delivery
|
GB0109297D0
(en)
*
|
2001-04-12 |
2001-05-30 |
Glaxosmithkline Biolog Sa |
Vaccine
|
CA2444391A1
(en)
*
|
2001-04-13 |
2002-10-24 |
Becton Dickinson And Company |
Methods and devices for administration of substances into the intradermal layer of skin for systemic absorption
|
JP2004520144A
(ja)
*
|
2001-04-27 |
2004-07-08 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
新規ワクチン
|
MY134424A
(en)
|
2001-05-30 |
2007-12-31 |
Saechsisches Serumwerk |
Stable influenza virus preparations with low or no amount of thiomersal
|
US20100221284A1
(en)
|
2001-05-30 |
2010-09-02 |
Saech-Sisches Serumwerk Dresden |
Novel vaccine composition
|
US20040236284A1
(en)
*
|
2001-06-08 |
2004-11-25 |
Hoste Shannon Marie-Lynn |
Needle hiding assembly for a medication injector
|
US20060018877A1
(en)
*
|
2001-06-29 |
2006-01-26 |
Mikszta John A |
Intradermal delivery of vacccines and therapeutic agents
|
BR0210628A
(pt)
*
|
2001-06-29 |
2004-08-10 |
Becton Dickinson Co |
Liberação intradérmica de vacinas e agentes terapêuticos genéticos via microcânula
|
US20050010193A1
(en)
*
|
2002-05-06 |
2005-01-13 |
Laurent Philippe E. |
Novel methods for administration of drugs and devices useful thereof
|
US20040120964A1
(en)
*
|
2001-10-29 |
2004-06-24 |
Mikszta John A. |
Needleless vaccination using chimeric yellow fever vaccine-vectored vaccines against heterologous flaviviruses
|
US6971999B2
(en)
|
2001-11-14 |
2005-12-06 |
Medical Instill Technologies, Inc. |
Intradermal delivery device and method
|
US7722595B2
(en)
*
|
2002-05-06 |
2010-05-25 |
Becton, Dickinson And Company |
Method and device for controlling drug pharmacokinetics
|
US20060264886A9
(en)
*
|
2002-05-06 |
2006-11-23 |
Pettis Ronald J |
Method for altering insulin pharmacokinetics
|
US20040147901A1
(en)
*
|
2002-07-08 |
2004-07-29 |
Medical Instill |
Intradermal delivery device, and method of intradermal delivery
|
CA2497086A1
(en)
*
|
2002-08-30 |
2004-03-11 |
Becton, Dickinson And Company |
Method of controlling pharmacokinetics of immunomodulatory compounds
|
EP1539281B1
(de)
*
|
2002-09-10 |
2007-05-30 |
Becton, Dickinson and Company |
Verfahren und vorrichtung zur epidermischen verabreichung einer substanz
|
US20040097882A1
(en)
|
2002-11-14 |
2004-05-20 |
Dibiasi Michael A. |
Self-aligning shield for syringe
|
CA2513029A1
(en)
*
|
2003-01-16 |
2004-08-05 |
John M. Brittingham |
Intradermal cellular delivery using narrow gauge micro-cannula
|
AU2004209917B8
(en)
*
|
2003-01-30 |
2010-05-06 |
Becton, Dickinson And Company |
Intradermal delivery device with contoured skin engaging surface geometry
|
JP2007500251A
(ja)
*
|
2003-06-13 |
2007-01-11 |
ベクトン・ディキンソン・アンド・カンパニー |
生物学的に活性な作用物質の改良型皮内送達
|
MXPA06002159A
(es)
*
|
2003-08-26 |
2006-05-22 |
Becton Dickinson Co |
Metodos para la administracion intradermica de agentes terapeuticos.
|
CA2536681C
(en)
|
2003-08-28 |
2011-07-05 |
Becton, Dickinson And Company |
Intradermal injection device
|
US20050054981A1
(en)
*
|
2003-09-04 |
2005-03-10 |
Romano Carlo Luca |
Auxiliary device for attenuating pain of injections, traumas, small lesions, hair removing operations, and inflammation conditions
|
ITMI20031706A1
(it)
*
|
2003-09-04 |
2005-03-05 |
Carlo Luca Romano' |
Dispositivo ausiliario per eseguire iniezioni.
|
WO2005034949A1
(en)
|
2003-09-09 |
2005-04-21 |
University Of Florida |
Desferrithiocin derivatives and their use as iron chelators
|
PL2332968T3
(pl)
|
2003-11-05 |
2017-08-31 |
Dana-Farber Cancer Institute, Inc. |
Stabilizowane alfa-helikalne peptydy i ich zastosowania
|
US20050256499A1
(en)
*
|
2004-03-03 |
2005-11-17 |
Pettis Ronald J |
Methods and devices for improving delivery of a substance to skin
|
US20050256182A1
(en)
*
|
2004-05-11 |
2005-11-17 |
Sutter Diane E |
Formulations of anti-pain agents and methods of using the same
|
CA2580103C
(en)
|
2004-09-22 |
2021-11-16 |
Glaxosmithkline Biologicals S.A. |
Immunogenic composition
|
US9492400B2
(en)
|
2004-11-04 |
2016-11-15 |
Massachusetts Institute Of Technology |
Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
|
EP1861122A1
(de)
|
2005-03-23 |
2007-12-05 |
GlaxoSmithKline Biologicals S.A. |
Zusammensetzung
|
MX2007012226A
(es)
|
2005-04-04 |
2007-12-10 |
Univ Florida |
Analogos de polieter de desferritiocina.
|
US20060264966A1
(en)
*
|
2005-05-12 |
2006-11-23 |
Med Institute, Inc. |
Vertebroplasty leak prevention sleeve and method
|
US9486274B2
(en)
|
2005-09-07 |
2016-11-08 |
Ulthera, Inc. |
Dissection handpiece and method for reducing the appearance of cellulite
|
US9358033B2
(en)
*
|
2005-09-07 |
2016-06-07 |
Ulthera, Inc. |
Fluid-jet dissection system and method for reducing the appearance of cellulite
|
US9011473B2
(en)
|
2005-09-07 |
2015-04-21 |
Ulthera, Inc. |
Dissection handpiece and method for reducing the appearance of cellulite
|
US10548659B2
(en)
*
|
2006-01-17 |
2020-02-04 |
Ulthera, Inc. |
High pressure pre-burst for improved fluid delivery
|
US8518069B2
(en)
|
2005-09-07 |
2013-08-27 |
Cabochon Aesthetics, Inc. |
Dissection handpiece and method for reducing the appearance of cellulite
|
US7842008B2
(en)
|
2005-11-21 |
2010-11-30 |
Becton, Dickinson And Company |
Intradermal delivery device
|
US7885793B2
(en)
|
2007-05-22 |
2011-02-08 |
International Business Machines Corporation |
Method and system for developing a conceptual model to facilitate generating a business-aligned information technology solution
|
US9248317B2
(en)
|
2005-12-02 |
2016-02-02 |
Ulthera, Inc. |
Devices and methods for selectively lysing cells
|
TWI457133B
(zh)
|
2005-12-13 |
2014-10-21 |
Glaxosmithkline Biolog Sa |
新穎組合物
|
US9267937B2
(en)
|
2005-12-15 |
2016-02-23 |
Massachusetts Institute Of Technology |
System for screening particles
|
ES2707499T3
(es)
|
2005-12-22 |
2019-04-03 |
Glaxosmithkline Biologicals Sa |
Vacuna de conjugado de polisacárido neumocócico
|
GB0607088D0
(en)
|
2006-04-07 |
2006-05-17 |
Glaxosmithkline Biolog Sa |
Vaccine
|
US7540860B2
(en)
*
|
2006-01-23 |
2009-06-02 |
Keith Stamler |
Wound irrigation splashback shield
|
US7666912B2
(en)
|
2006-03-23 |
2010-02-23 |
Massachusetts Eye And Ear Infirmary |
Compositions and methods for reducing body fat
|
EP1998802A2
(de)
|
2006-03-30 |
2008-12-10 |
GlaxoSmithKline Biologicals S.A. |
Immunogene zusammensetzung
|
ES2776100T3
(es)
|
2006-03-31 |
2020-07-29 |
Massachusetts Inst Technology |
Sistema para el suministro dirigido de agentes terapéuticos
|
US7789856B2
(en)
*
|
2006-05-15 |
2010-09-07 |
Hillios Christopher H |
Injection aid and stability disk for syringe or insulin pen
|
US8361019B2
(en)
|
2006-05-15 |
2013-01-29 |
Hillios Christopher H |
Injection aid and stability disk for syringe or insulin pen
|
CN101573141B
(zh)
|
2006-05-15 |
2016-05-04 |
麻省理工学院 |
用于功能性颗粒的聚合物
|
US9150626B2
(en)
|
2006-06-02 |
2015-10-06 |
President And Fellows Of Harvard College |
Protein surface remodeling
|
WO2007150030A2
(en)
|
2006-06-23 |
2007-12-27 |
Massachusetts Institute Of Technology |
Microfluidic synthesis of organic nanoparticles
|
EP2422810B1
(de)
|
2006-07-17 |
2014-10-22 |
GlaxoSmithKline Biologicals s.a. |
Influenzaimpfstoff
|
KR101696727B1
(ko)
|
2006-07-17 |
2017-01-16 |
글락소스미스클라인 바이오로지칼즈 에스.에이. |
인플루엔자 백신
|
WO2008021367A2
(en)
|
2006-08-11 |
2008-02-21 |
President And Fellows Of Harvard College |
Moenomycin biosynthesis-related compositions and methods of use thereof
|
JO3598B1
(ar)
|
2006-10-10 |
2020-07-05 |
Infinity Discovery Inc |
الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
|
PL2086582T3
(pl)
|
2006-10-12 |
2013-04-30 |
Glaxosmithkline Biologicals Sa |
Kompozycja zawierająca adiuwant w postaci emulsji typu olej w wodzie
|
CN101522218B
(zh)
|
2006-10-12 |
2012-09-26 |
葛兰素史密丝克莱恩生物有限公司 |
包含水包油乳液佐剂的疫苗
|
CA2671447A1
(en)
|
2006-12-01 |
2008-06-12 |
Anterios, Inc. |
Amphiphilic entity nanoparticles
|
CN105622463B
(zh)
|
2006-12-26 |
2019-02-22 |
兰休斯医疗成像公司 |
用于使心脏神经支配成像的配体
|
PT2118123E
(pt)
|
2007-01-31 |
2016-02-10 |
Harvard College |
Péptidos de p53 estabilizados e suas utilizações
|
WO2008098165A2
(en)
|
2007-02-09 |
2008-08-14 |
Massachusetts Institute Of Technology |
Oscillating cell culture bioreactor
|
CN100457206C
(zh)
*
|
2007-03-07 |
2009-02-04 |
中国人民解放军第二军医大学 |
可调式搏动心肌内注入器
|
WO2008115433A1
(en)
|
2007-03-15 |
2008-09-25 |
University Of Florida |
Desferrithiocin polyether analogues
|
US7960139B2
(en)
|
2007-03-23 |
2011-06-14 |
Academia Sinica |
Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
|
EP2508531B1
(de)
|
2007-03-28 |
2016-10-19 |
President and Fellows of Harvard College |
Geheftete Polypeptide
|
WO2008124639A2
(en)
|
2007-04-04 |
2008-10-16 |
Massachusetts Institute Of Technology |
Poly (amino acid) targeting moieties
|
AR066405A1
(es)
|
2007-04-20 |
2009-08-19 |
Glaxosmithkline Biolog Sa |
Vacuna
|
BRPI0810582A2
(pt)
|
2007-04-23 |
2015-10-27 |
Program For Appropriate Technology In Health |
métodos e dispositivos para injeção intradérmica
|
WO2008156676A1
(en)
|
2007-06-15 |
2008-12-24 |
President And Fellows Of Harvard College |
Methods and compositions for detecting and modulating o-glycosylation
|
RS54349B1
(en)
|
2007-06-26 |
2016-02-29 |
Glaxosmithkline Biologicals S.A. |
VACCINE CONTAINING STREPTOCOCCUS PNEUMONIAE Capsular POLYSACCHARIDE CONJUGATES
|
US8604004B2
(en)
|
2007-10-04 |
2013-12-10 |
President And Fellows Of Harvard College |
Moenomycin analogs, methods of synthesis, and uses thereof
|
US8439940B2
(en)
|
2010-12-22 |
2013-05-14 |
Cabochon Aesthetics, Inc. |
Dissection handpiece with aspiration means for reducing the appearance of cellulite
|
CN105770878A
(zh)
|
2007-10-12 |
2016-07-20 |
麻省理工学院 |
疫苗纳米技术
|
CA2711330A1
(en)
|
2008-01-03 |
2009-07-16 |
Massachusetts Institute Of Technology |
Decoy influenza therapies
|
US8193182B2
(en)
|
2008-01-04 |
2012-06-05 |
Intellikine, Inc. |
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
|
JP2008110260A
(ja)
*
|
2008-02-04 |
2008-05-15 |
Terumo Corp |
注射針用穿刺調整具およびそれを備えた注射針組立体
|
WO2009126691A1
(en)
|
2008-04-09 |
2009-10-15 |
Infinity Pharmaceuticals, Inc |
Inhibitors of fatty acid amide hydrolase
|
WO2009127676A1
(en)
|
2008-04-16 |
2009-10-22 |
Glaxosmithkline Biologicals S.A. |
Vaccine
|
CN105147608B
(zh)
|
2008-06-26 |
2019-12-10 |
安特里奥公司 |
真皮递送
|
US8680020B2
(en)
|
2008-07-15 |
2014-03-25 |
Academia Sinica |
Glycan arrays on PTFE-like aluminum coated glass slides and related methods
|
WO2010010488A1
(en)
*
|
2008-07-21 |
2010-01-28 |
Wockhardt Research Centre |
Device for attachment to a needle assembly to vary the length of the needle being exposed
|
US20110144306A1
(en)
|
2008-07-23 |
2011-06-16 |
President And Fellows Of Harvard College |
Ligation of stapled polypeptides
|
US9206223B2
(en)
|
2008-09-22 |
2015-12-08 |
Aileron Therapeutics, Inc. |
Methods for preparing purified polypeptide compositions
|
US8343498B2
(en)
|
2008-10-12 |
2013-01-01 |
Massachusetts Institute Of Technology |
Adjuvant incorporation in immunonanotherapeutics
|
US8277812B2
(en)
|
2008-10-12 |
2012-10-02 |
Massachusetts Institute Of Technology |
Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
|
US8343497B2
(en)
|
2008-10-12 |
2013-01-01 |
The Brigham And Women's Hospital, Inc. |
Targeting of antigen presenting cells with immunonanotherapeutics
|
US8591905B2
(en)
|
2008-10-12 |
2013-11-26 |
The Brigham And Women's Hospital, Inc. |
Nicotine immunonanotherapeutics
|
CA2742813C
(en)
|
2008-11-07 |
2016-11-29 |
Becton, Dickinson And Company |
Syringe housing to facilitate medication injection
|
CA2743904A1
(en)
|
2008-11-17 |
2010-05-20 |
The Regents Of The University Of Michigan |
Cancer vaccine compositions and methods of using the same
|
WO2010064211A2
(en)
*
|
2008-12-04 |
2010-06-10 |
Nanopass Technologies Ltd. |
Intradermal mini-needle interface and associated devices and methods
|
US20110224609A1
(en)
*
|
2008-12-08 |
2011-09-15 |
Sid Technologies, Llc |
Alignment of a Needle in an Intradermal Injection Device
|
EP2376619A4
(de)
|
2008-12-15 |
2012-07-04 |
Greenlight Biosciences Inc |
Verfahren zur flusssteuerung bei stoffwechselwegen
|
CN102256615A
(zh)
|
2009-01-14 |
2011-11-23 |
爱勒让治疗公司 |
拟肽大环化合物
|
TWI449551B
(zh)
|
2009-01-30 |
2014-08-21 |
Terumo Corp |
注射針組合體以及藥劑注射裝置
|
JP2012525146A
(ja)
|
2009-04-28 |
2012-10-22 |
プレジデント アンド フェロウズ オブ ハーバード カレッジ |
細胞透過のための過剰に荷電されたタンパク質
|
US8927551B2
(en)
|
2009-05-18 |
2015-01-06 |
Infinity Pharmaceuticals, Inc. |
Isoxazolines as inhibitors of fatty acid amide hydrolase
|
US9149465B2
(en)
|
2009-05-18 |
2015-10-06 |
Infinity Pharmaceuticals, Inc. |
Isoxazolines as inhibitors of fatty acid amide hydrolase
|
US8765735B2
(en)
|
2009-05-18 |
2014-07-01 |
Infinity Pharmaceuticals, Inc. |
Isoxazolines as inhibitors of fatty acid amide hydrolase
|
WO2010141074A2
(en)
|
2009-06-01 |
2010-12-09 |
President And Fellows Of Harvard College |
O-glcnac transferase inhibitors and uses thereof
|
US9163330B2
(en)
|
2009-07-13 |
2015-10-20 |
President And Fellows Of Harvard College |
Bifunctional stapled polypeptides and uses thereof
|
CN102648016A
(zh)
|
2009-07-23 |
2012-08-22 |
适宜卫生科技项目公司 |
皮内注射适配器
|
GB0913681D0
(en)
|
2009-08-05 |
2009-09-16 |
Glaxosmithkline Biolog Sa |
Immunogenic composition
|
US9358064B2
(en)
|
2009-08-07 |
2016-06-07 |
Ulthera, Inc. |
Handpiece and methods for performing subcutaneous surgery
|
US11096708B2
(en)
|
2009-08-07 |
2021-08-24 |
Ulthera, Inc. |
Devices and methods for performing subcutaneous surgery
|
CA2774973A1
(en)
|
2009-09-22 |
2011-03-31 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
CA2776144C
(en)
|
2009-09-29 |
2020-10-27 |
Fraunhofer Usa, Inc. |
Influenza hemagglutinin antibodies, compositions, and related methods
|
MY159863A
(en)
|
2009-09-30 |
2017-02-15 |
Terumo Corp |
Injection needle assembly and drug injection device
|
GB0919117D0
(en)
|
2009-10-30 |
2009-12-16 |
Glaxosmithkline Biolog Sa |
Process
|
US10087236B2
(en)
|
2009-12-02 |
2018-10-02 |
Academia Sinica |
Methods for modifying human antibodies by glycan engineering
|
US11377485B2
(en)
|
2009-12-02 |
2022-07-05 |
Academia Sinica |
Methods for modifying human antibodies by glycan engineering
|
WO2011094445A1
(en)
|
2010-01-27 |
2011-08-04 |
Massachusetts Institute Of Technology |
Engineered polypeptide agents for targeted broad spectrum influenza neutralization
|
KR101888026B1
(ko)
|
2010-02-03 |
2018-08-13 |
인피니티 파마슈티컬스, 인코포레이티드 |
지방산 아미드 하이드롤라제 저해제
|
CN102844023B
(zh)
|
2010-03-08 |
2016-01-20 |
索隆-基特林癌症研究协会 |
Cdc7激酶抑制剂以及其用途
|
GB201003922D0
(en)
|
2010-03-09 |
2010-04-21 |
Glaxosmithkline Biolog Sa |
Conjugation process
|
GB201003920D0
(en)
|
2010-03-09 |
2010-04-21 |
Glaxosmithkline Biolog Sa |
Method of treatment
|
WO2011112916A1
(en)
|
2010-03-12 |
2011-09-15 |
Sid Technologies, Llc |
Assembly for use with a syringe
|
WO2011119549A1
(en)
|
2010-03-22 |
2011-09-29 |
President And Fellows Of Harvard College |
Trioxacarcins and uses thereof
|
WO2011130332A1
(en)
|
2010-04-12 |
2011-10-20 |
Academia Sinica |
Glycan arrays for high throughput screening of viruses
|
US8450350B2
(en)
|
2010-05-05 |
2013-05-28 |
Infinity Pharmaceuticals, Inc. |
Triazoles as inhibitors of fatty acid synthase
|
EP2566853B1
(de)
|
2010-05-05 |
2017-01-25 |
Infinity Pharmaceuticals, Inc. |
Tetrazolone als fettsäuresynthasehemmer
|
DK2566953T3
(en)
|
2010-05-07 |
2019-04-15 |
Greenlight Biosciences Inc |
METHODS OF MANAGING THE POWER BY METABOLIC ROADS USING ENZYMOUS LOCATION
|
RU2019142507A
(ru)
|
2010-05-11 |
2020-08-24 |
Лантеус Медикал Имэджинг, Инк. |
Композиции, способы и системы для синтеза и применение визуализирующих средств
|
CN103180318B
(zh)
|
2010-05-14 |
2017-05-10 |
达那-法伯癌症研究所 |
雄性避孕组合物以及使用方法
|
US9193989B2
(en)
|
2010-06-18 |
2015-11-24 |
Taiho Pharmaceutical Co., Ltd. |
PRPK-TPRKB modulators and uses thereof
|
CA2807552A1
(en)
|
2010-08-06 |
2012-02-09 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
CA2807685C
(en)
|
2010-08-13 |
2020-10-06 |
Aileron Therapeutics, Inc. |
P53 derived peptidomimetic macrocycle
|
CA2809284C
(en)
|
2010-08-31 |
2021-02-23 |
Greenlight Biosciences, Inc. |
Methods for control of flux in metabolic pathways through protease manipulation
|
US8802110B2
(en)
|
2010-09-21 |
2014-08-12 |
Massachusetts Institute Of Technology |
Influenza treatment and/or characterization, human-adapted HA polypeptides; vaccines
|
US8957026B2
(en)
|
2010-09-22 |
2015-02-17 |
President And Fellows Of Harvard College |
Beta-catenin targeting peptides and uses thereof
|
ES2862955T3
(es)
|
2010-10-01 |
2021-10-08 |
Modernatx Inc |
Acidos nucleicos manipulados y métodos de uso de los mismos
|
RU2663718C2
(ru)
|
2010-10-04 |
2018-08-08 |
Массачусетс Инститьют Оф Текнолоджи |
Полипептиды гемагглютининов, а также связанные с ними реагенты и способы
|
CA2817577A1
(en)
|
2010-11-10 |
2012-05-18 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
DK2663309T3
(en)
|
2011-01-10 |
2017-06-19 |
Infinity Pharmaceuticals Inc |
METHODS FOR PRODUCING ISOQUINOLINONES AND SOLID FORMS OF ISOQUINOLINONES
|
WO2012099942A2
(en)
|
2011-01-19 |
2012-07-26 |
Terakine Therapeutics, Inc. |
Methods and compositions for treating metabolic syndrome
|
EP2489379B1
(de)
|
2011-01-21 |
2020-09-23 |
SID Technologies, LLC |
Intradermaler Stiftadapter
|
BR112013018920A2
(pt)
|
2011-01-24 |
2017-11-28 |
Anterios Inc |
composições de nanopartículas, formulações destas e seus usos
|
JP2014503586A
(ja)
|
2011-01-24 |
2014-02-13 |
アンテリオス, インコーポレイテッド |
油組成物
|
CN103747782A
(zh)
|
2011-01-24 |
2014-04-23 |
安特里奥公司 |
纳米颗粒组合物
|
KR20140010126A
(ko)
|
2011-03-03 |
2014-01-23 |
터서스 파마수티칼 엘엘씨 |
C16:1n7-팔미톨리에이트를 포함하는 조성물들 및 방법들
|
GB201103836D0
(en)
|
2011-03-07 |
2011-04-20 |
Glaxosmithkline Biolog Sa |
Conjugation process
|
US9193767B2
(en)
|
2011-03-30 |
2015-11-24 |
Brown University |
Enopeptins, uses thereof, and methods of synthesis thereto
|
US8710200B2
(en)
|
2011-03-31 |
2014-04-29 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids encoding a modified erythropoietin and their expression
|
JP5894582B2
(ja)
*
|
2011-04-28 |
2016-03-30 |
テルモ株式会社 |
注射針組立体及び薬剤注射装置
|
WO2012147408A1
(ja)
*
|
2011-04-28 |
2012-11-01 |
テルモ株式会社 |
注射針組立体及び薬剤注射装置
|
UY34073A
(es)
|
2011-05-17 |
2013-01-03 |
Glaxosmithkline Biolog Sa |
Vacuna mejorada de streptococcus pneumoniae y métodos de preparación.
|
CA2840224C
(en)
|
2011-06-22 |
2019-08-13 |
The General Hospital Corporation |
Treatment of proteinopathies
|
AU2012284088B2
(en)
|
2011-07-19 |
2015-10-08 |
Infinity Pharmaceuticals Inc. |
Heterocyclic compounds and uses thereof
|
MX2014000648A
(es)
|
2011-07-19 |
2014-09-25 |
Infinity Pharmaceuticals Inc |
Compuestos heterociclicos y sus usos.
|
RS58438B1
(sr)
|
2011-07-22 |
2019-04-30 |
Massachusetts Inst Technology |
Aktivatori klase i histonskih deacetilaza (hdacs) i njihova primena
|
WO2013019830A2
(en)
|
2011-08-01 |
2013-02-07 |
Alcyone Lifesciences, Inc. |
Microfluidic drug delivery devices
|
KR20140075693A
(ko)
|
2011-08-29 |
2014-06-19 |
인피니티 파마슈티칼스, 인코포레이티드 |
헤테로사이클릭 화합물 및 그의 용도
|
JP2014526250A
(ja)
|
2011-09-09 |
2014-10-06 |
グリーンライト バイオサイエンシーズ インコーポレーテッド |
カルバペネムの無細胞調製
|
DK2753605T3
(da)
|
2011-09-09 |
2019-06-17 |
Lantheus Medical Imaging Inc |
Sammensætninger, fremgangsmåder, og systemer til syntesen og anvendelsen af billeddannelsesmidler
|
EP3384938A1
(de)
|
2011-09-12 |
2018-10-10 |
Moderna Therapeutics, Inc. |
Manipulierte nukleinsäuren und verfahren zur verwendung davon
|
US9630979B2
(en)
|
2011-09-29 |
2017-04-25 |
Infinity Pharmaceuticals, Inc. |
Inhibitors of monoacylglycerol lipase and methods of their use
|
WO2013052523A1
(en)
|
2011-10-03 |
2013-04-11 |
modeRNA Therapeutics |
Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
|
TWI643868B
(zh)
|
2011-10-18 |
2018-12-11 |
艾利倫治療公司 |
擬肽巨環化合物
|
EP2589401A1
(de)
|
2011-11-04 |
2013-05-08 |
Fiderm S.r.l. (Ricerca e Technogie in Scienze Dermatologiche) |
Vorrichtung zur Steuerung der Tiefe und zur Reduzierung des Schmerzes von Injektionen
|
JP6424089B2
(ja)
*
|
2011-11-07 |
2018-11-14 |
イーライ リリー アンド カンパニー |
人間工学的改善を施した注射器具
|
EP2822935B1
(de)
|
2011-11-17 |
2019-05-15 |
Dana-Farber Cancer Institute, Inc. |
Inhibitoren der c-jun-n-terminal-kinase (jnk)
|
GB201120000D0
(en)
|
2011-11-20 |
2012-01-04 |
Glaxosmithkline Biolog Sa |
Vaccine
|
GB201119999D0
(en)
|
2011-11-20 |
2012-01-04 |
Glaxosmithkline Biolog Sa |
Vaccine
|
CN104114572A
(zh)
|
2011-12-16 |
2014-10-22 |
现代治疗公司 |
经修饰的核苷、核苷酸和核酸组合物
|
US8426471B1
(en)
|
2011-12-19 |
2013-04-23 |
Topokine Therapeutics, Inc. |
Methods and compositions for reducing body fat and adipocytes
|
US8987414B2
(en)
|
2012-02-15 |
2015-03-24 |
Aileron Therapeutics, Inc. |
Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
|
MX362492B
(es)
|
2012-02-15 |
2019-01-21 |
Aileron Therapeutics Inc |
Macrociclos peptidomiméticos.
|
ITMO20120040A1
(it)
|
2012-02-16 |
2013-08-17 |
Lameplast Spa |
Dispositivo per il controllo della profondita' di penetrazione di un ago per iniezioni
|
GB201205189D0
(en)
|
2012-03-23 |
2012-05-09 |
Glaxosmithkline Biolog Sa |
Novel medical use
|
WO2013151697A1
(en)
|
2012-04-06 |
2013-10-10 |
President And Fellows Of Harvard College |
Methods and compounds for identifying glycosyltransferase inhibitors
|
EP2850090B1
(de)
|
2012-04-06 |
2018-10-03 |
President and Fellows of Harvard College |
Chemoenzymatische verfahren zur synthetisierung von moenomycin-analoga
|
EP2834254A2
(de)
|
2012-04-06 |
2015-02-11 |
President and Fellows of Harvard College |
Moenomycin-analoga, syntheseverfahren und verwendung
|
US8940742B2
(en)
|
2012-04-10 |
2015-01-27 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
US10130714B2
(en)
|
2012-04-14 |
2018-11-20 |
Academia Sinica |
Enhanced anti-influenza agents conjugated with anti-inflammatory activity
|
US9597385B2
(en)
|
2012-04-23 |
2017-03-21 |
Allertein Therapeutics, Llc |
Nanoparticles for treatment of allergy
|
BR112014027991A2
(pt)
|
2012-05-10 |
2017-07-18 |
Massachusetts Inst Technology |
agentes para neutralização de influenza
|
WO2014024026A1
(en)
|
2012-08-06 |
2014-02-13 |
Glaxosmithkline Biologicals S.A. |
Method for eliciting in infants an immune response against rsv and b. pertussis
|
US20140037680A1
(en)
|
2012-08-06 |
2014-02-06 |
Glaxosmithkline Biologicals, S.A. |
Novel method
|
AU2013203000B9
(en)
|
2012-08-10 |
2017-02-02 |
Lantheus Medical Imaging, Inc. |
Compositions, methods, and systems for the synthesis and use of imaging agents
|
CA2880701A1
(en)
|
2012-08-18 |
2014-02-27 |
Academia Sinica |
Cell-permeable probes for identification and imaging of sialidases
|
ES2674145T3
(es)
*
|
2012-09-11 |
2018-06-27 |
Karim-Frédéric Marti |
Dispositivo para reducir el dolor relacionado con la introducción en la piel de una aguja de una jeringa
|
WO2014052647A2
(en)
|
2012-09-26 |
2014-04-03 |
President And Fellows Of Harvard College |
Proline-locked stapled peptides and uses thereof
|
US20150225471A1
(en)
|
2012-10-01 |
2015-08-13 |
President And Fellows Of Harvard College |
Stabilized polypeptide insulin receptor modulators
|
ES2719776T3
(es)
|
2012-10-12 |
2019-07-16 |
Broad Inst Inc |
Inhibidores de GSK3 y métodos de uso de los mismos
|
EP2909194A1
(de)
|
2012-10-18 |
2015-08-26 |
Dana-Farber Cancer Institute, Inc. |
Hemmer der cyclinabhängigen kinase 7 (cdk7)
|
USRE48175E1
(en)
|
2012-10-19 |
2020-08-25 |
Dana-Farber Cancer Institute, Inc. |
Hydrophobically tagged small molecules as inducers of protein degradation
|
WO2014063054A1
(en)
|
2012-10-19 |
2014-04-24 |
Dana-Farber Cancer Institute, Inc. |
Bone marrow on x chromosome kinase (bmx) inhibitors and uses thereof
|
EP2914256B1
(de)
|
2012-11-01 |
2019-07-31 |
Aileron Therapeutics, Inc. |
Disubstituierte aminosäuren und verfahren zur herstellung und verwendung davon
|
DK2914296T4
(da)
|
2012-11-01 |
2022-01-03 |
Infinity Pharmaceuticals Inc |
Behandling af cancere under anvendelse af PI3-kinase-isoform-modulatorer
|
EP2917203B1
(de)
|
2012-11-02 |
2019-04-03 |
Dana-Farber Cancer Institute, Inc. |
Verfahren zur identifizierung von myc inhibitoren
|
KR101651448B1
(ko)
|
2012-11-21 |
2016-08-26 |
토포카인 쎄라퓨틱스, 인코포레이티드 |
체지방을 국소적으로 증가시키는 방법 및 조성물
|
PL2922554T3
(pl)
|
2012-11-26 |
2022-06-20 |
Modernatx, Inc. |
Na zmodyfikowany na końcach
|
JP6408478B2
(ja)
|
2012-11-26 |
2018-10-17 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
トリオキサカルシン、トリオキサカルシン−抗体複合体、およびその用途
|
EP2934627B1
(de)
|
2012-12-18 |
2021-04-07 |
Alcyone Lifesciences, Inc. |
Vorrichtungen und verfahren zur verminderung oder verhinderung von rückstrom in einem abgabesystem
|
US9745291B2
(en)
|
2012-12-21 |
2017-08-29 |
Epizyme, Inc. |
PRMT5 inhibitors containing a dihydro- or tetrahydroisoquinoline and uses thereof
|
JP2016505001A
(ja)
|
2012-12-21 |
2016-02-18 |
エピザイム,インコーポレイティド |
Prmt5阻害剤およびその使用
|
WO2014100695A1
(en)
|
2012-12-21 |
2014-06-26 |
Epizyme, Inc. |
Prmt5 inhibitors and uses thereof
|
MX2015008052A
(es)
|
2012-12-21 |
2016-08-18 |
Epizyme Inc |
Inhibidores de prmt5 y sus usos.
|
EP2946014A2
(de)
|
2013-01-17 |
2015-11-25 |
Moderna Therapeutics, Inc. |
Signal-sensor-polynukleotide zur veränderung zellulärer phänotypen
|
US20140335504A1
(en)
|
2013-02-07 |
2014-11-13 |
Massachusetts Institute Of Technology |
Human adaptation of h5 influenza
|
US20160024181A1
(en)
|
2013-03-13 |
2016-01-28 |
Moderna Therapeutics, Inc. |
Long-lived polynucleotide molecules
|
US10081654B2
(en)
|
2013-03-13 |
2018-09-25 |
President And Fellows Of Harvard College |
Stapled and stitched polypeptides and uses thereof
|
US9597463B2
(en)
|
2013-03-14 |
2017-03-21 |
Boston Scientific Scimed, Inc. |
Injection devices with controllable depth adjustability and methods of use
|
EP2970194A1
(de)
|
2013-03-15 |
2016-01-20 |
Infinity Pharmaceuticals, Inc. |
Salze und feste formen von isochinolinonen und zusammensetzung damit sowie verfahren zur verwendung davon
|
US9345618B2
(en)
*
|
2013-03-26 |
2016-05-24 |
Crt Technology Inc. |
Ocular device
|
KR102233251B1
(ko)
|
2013-04-03 |
2021-03-26 |
엔-폴드 엘엘씨 |
신규 나노입자 조성물
|
EP2988597B1
(de)
|
2013-04-04 |
2022-06-08 |
President and Fellows of Harvard College |
Makrolide sowie verfahren zu deren herstellung und verwendung
|
ES2774330T3
(es)
|
2013-04-09 |
2020-07-20 |
Massachusetts Inst Technology |
Polímero de suministro de fármaco y usos del mismo
|
US9474865B2
(en)
|
2013-04-25 |
2016-10-25 |
West Pharmaceutical Services, Inc. |
Needle shield for disposable syringe with annular ring
|
WO2014179464A1
(en)
|
2013-04-30 |
2014-11-06 |
Massachusetts Institute Of Technology |
Human adaptation of h3 influenza
|
WO2014179562A1
(en)
|
2013-05-01 |
2014-11-06 |
Massachusetts Institute Of Technology |
1,3,5-triazinane-2,4,6-trione derivatives and uses thereof
|
NO2753788T3
(de)
|
2013-05-10 |
2018-06-16 |
|
|
DK3003309T3
(da)
|
2013-05-30 |
2020-12-14 |
Infinity Pharmaceuticals Inc |
Behandling af cancer med PI3-kinase-isoform modulatorer
|
US10526375B2
(en)
|
2013-06-05 |
2020-01-07 |
Massachusetts Institute Of Technology |
Human Adaptation of H7 HA
|
US9212145B2
(en)
|
2013-06-11 |
2015-12-15 |
Kala Pharmaceuticals, Inc. |
Urea derivatives and uses thereof
|
AU2014278005B2
(en)
|
2013-06-14 |
2018-11-22 |
President And Fellows Of Harvard College |
Stabilized polypeptide insulin receptor modulators
|
US10456533B2
(en)
|
2013-06-17 |
2019-10-29 |
Alcyone Lifesciences, Inc. |
Methods and devices for protecting catheter tips and stereotactic fixtures for microcatheters
|
WO2014210397A1
(en)
|
2013-06-26 |
2014-12-31 |
Academia Sinica |
Rm2 antigens and use thereof
|
US9981030B2
(en)
|
2013-06-27 |
2018-05-29 |
Academia Sinica |
Glycan conjugates and use thereof
|
EP3024327B1
(de)
|
2013-07-25 |
2019-09-04 |
Dana-Farber Cancer Institute, Inc. |
Hemmer von transkriptionsfaktoren und verwendungen davon
|
US10441770B2
(en)
|
2013-07-31 |
2019-10-15 |
Alcyone Lifesciences, Inc. |
Systems and methods for drug delivery, treatment, and monitoring
|
WO2015021058A2
(en)
|
2013-08-05 |
2015-02-12 |
Greenlight Biosciences, Inc. |
Engineered proteins with a protease cleavage site
|
EP3030260A1
(de)
|
2013-08-05 |
2016-06-15 |
GlaxoSmithKline Biologicals S.A. |
Immunogene kombinationszusammensetzungen
|
CA2923579C
(en)
|
2013-09-06 |
2023-09-05 |
Academia Sinica |
Human inkt cell activation using glycolipids with altered glycosyl groups
|
CN104436157A
(zh)
|
2013-09-23 |
2015-03-25 |
恩金生物有限公司 |
流感疫苗和治疗
|
WO2015051241A1
(en)
|
2013-10-04 |
2015-04-09 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
NZ718430A
(en)
|
2013-10-04 |
2021-12-24 |
Infinity Pharmaceuticals Inc |
Heterocyclic compounds and uses thereof
|
WO2015057894A1
(en)
|
2013-10-15 |
2015-04-23 |
Massachusetts Institute Of Technology |
Methods for treating polycystic kidney disease and polycystic liver disease
|
US9902986B2
(en)
|
2013-10-16 |
2018-02-27 |
Massachusetts Institute Of Technology |
Enterobactin conjugates and uses thereof
|
JP6491202B2
(ja)
|
2013-10-18 |
2019-03-27 |
デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド |
サイクリン依存性キナーゼ7(cdk7)の多環阻害剤
|
US20160244452A1
(en)
|
2013-10-21 |
2016-08-25 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
AU2014342042B2
(en)
|
2013-11-01 |
2017-08-17 |
KALA BIO, Inc. |
Crystalline forms of therapeutic compounds and uses thereof
|
US11446309B2
(en)
|
2013-11-08 |
2022-09-20 |
Dana-Farber Cancer Institute, Inc. |
Combination therapy for cancer using bromodomain and extra-terminal (BET) protein inhibitors
|
CN106103452B
(zh)
|
2013-12-24 |
2019-05-21 |
哈佛学院院长等 |
皮质抑素类似物及其合成和用途
|
TW201620939A
(zh)
|
2014-01-16 |
2016-06-16 |
中央研究院 |
治療及檢測癌症之組合物及方法
|
US10150818B2
(en)
|
2014-01-16 |
2018-12-11 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
US10793571B2
(en)
|
2014-01-31 |
2020-10-06 |
Dana-Farber Cancer Institute, Inc. |
Uses of diazepane derivatives
|
JP2017506666A
(ja)
|
2014-02-28 |
2017-03-09 |
テンシャ セラピューティクス,インコーポレイテッド |
高インスリン血症に関連した症状の処置
|
WO2015134920A1
(en)
|
2014-03-07 |
2015-09-11 |
The Arizona Board Of Regents On Behalf Of The University Of Arizona |
Non-narcotic crmp2 peptides targeting sodium channels for chronic pain
|
EA201691872A1
(ru)
|
2014-03-19 |
2017-04-28 |
Инфинити Фармасьютикалз, Инк. |
Гетероциклические соединения для применения в лечении pi3k-гамма-опосредованных расстройств
|
JP6562942B2
(ja)
|
2014-03-27 |
2019-08-28 |
アカデミア シニカAcademia Sinica |
反応性標識化合物およびその使用
|
CN106456735B
(zh)
|
2014-03-28 |
2021-06-29 |
华盛顿大学商业中心 |
乳腺癌和卵巢癌疫苗
|
WO2015168079A1
(en)
|
2014-04-29 |
2015-11-05 |
Infinity Pharmaceuticals, Inc. |
Pyrimidine or pyridine derivatives useful as pi3k inhibitors
|
US10039816B2
(en)
|
2014-04-30 |
2018-08-07 |
Massachusetts Institute Of Technology |
Siderophore-based immunization against gram-negative bacteria
|
WO2015179635A2
(en)
|
2014-05-21 |
2015-11-26 |
President And Fellows Of Harvard College |
Ras inhibitory peptides and uses thereof
|
WO2015184008A1
(en)
|
2014-05-27 |
2015-12-03 |
Academia Sinica |
Fucosidase from bacteroides and methods using the same
|
US10118969B2
(en)
|
2014-05-27 |
2018-11-06 |
Academia Sinica |
Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
|
AU2015267045B2
(en)
|
2014-05-27 |
2021-02-25 |
Academia Sinica |
Anti-HER2 glycoantibodies and uses thereof
|
JP2017518989A
(ja)
|
2014-05-27 |
2017-07-13 |
アカデミア シニカAcademia Sinica |
抗cd20糖操作抗体群およびその使用
|
TWI732738B
(zh)
|
2014-05-28 |
2021-07-11 |
中央研究院 |
抗TNF-α醣抗體及其用途
|
JP6664338B2
(ja)
|
2014-06-13 |
2020-03-13 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
免疫原性組合せ物
|
CN106559991B
(zh)
|
2014-06-19 |
2019-09-20 |
阿里亚德医药股份有限公司 |
用于激酶抑制的杂芳基化合物
|
WO2015200425A1
(en)
|
2014-06-27 |
2015-12-30 |
Topokine Therapeutics, Inc. |
Topical dosage regimen
|
CN106573038A
(zh)
|
2014-06-30 |
2017-04-19 |
默多克儿童研究所 |
螺杆菌治疗剂
|
EP3164379A1
(de)
|
2014-07-02 |
2017-05-10 |
Massachusetts Institute of Technology |
Lipidoide aus polyaminfettsäure und verwendungen davon
|
WO2016011386A1
(en)
|
2014-07-18 |
2016-01-21 |
University Of Washington |
Cancer vaccine compositions and methods of use thereof
|
WO2016019160A1
(en)
*
|
2014-07-30 |
2016-02-04 |
University Of Kansas |
Cannula for external drainage of subretinal fluid
|
US10736966B2
(en)
|
2014-08-12 |
2020-08-11 |
Massachusetts Institute Of Technology |
Brush-poly (glycoamidoamine)-lipids and uses thereof
|
CA2960712A1
(en)
|
2014-09-08 |
2016-03-17 |
Academia Sinica |
Human inkt cell activation using glycolipids
|
CN107106642B
(zh)
|
2014-09-24 |
2021-02-26 |
艾瑞朗医疗公司 |
拟肽大环化合物及其制剂
|
SG10201902594QA
(en)
|
2014-09-24 |
2019-04-29 |
Aileron Therapeutics Inc |
Peptidomimetic macrocycles and uses thereof
|
US9708348B2
(en)
|
2014-10-03 |
2017-07-18 |
Infinity Pharmaceuticals, Inc. |
Trisubstituted bicyclic heterocyclic compounds with kinase activities and uses thereof
|
AU2015335950B2
(en)
|
2014-10-21 |
2018-01-25 |
Takeda Pharmaceutical Company Limited |
Crystalline forms of 5-chloro-N4-[-2-(dimethylphosphoryl) phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl) piperidin-1-yl] phenyl}pyrimidine-2,4-diamine
|
CA2965330A1
(en)
|
2014-10-27 |
2016-05-06 |
Tensha Therapeutics, Inc. |
Bromodomain inhibitors
|
JP2017533238A
(ja)
|
2014-10-28 |
2017-11-09 |
アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル |
抗原特異的寛容のための組成物及び方法
|
WO2016077125A1
(en)
|
2014-11-10 |
2016-05-19 |
Moderna Therapeutics, Inc. |
Alternative nucleic acid molecules containing reduced uracil content and uses thereof
|
WO2016086026A1
(en)
|
2014-11-26 |
2016-06-02 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of a therapeutic compound and uses thereof
|
US10174022B2
(en)
|
2014-12-10 |
2019-01-08 |
Kala Pharmaceuticals, Inc. |
1-amino-triazolo(1,5-A)pyridine-substituted urea derivative and uses thereof
|
US10314815B2
(en)
|
2014-12-23 |
2019-06-11 |
Sloan-Kettering Institute For Cancer Research |
Polymorph of granaticin B
|
US9975965B2
(en)
|
2015-01-16 |
2018-05-22 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
US10495645B2
(en)
|
2015-01-16 |
2019-12-03 |
Academia Sinica |
Cancer markers and methods of use thereof
|
JP6779887B2
(ja)
|
2015-01-24 |
2020-11-04 |
アカデミア シニカAcademia Sinica |
新規なグリカンコンジュゲートおよびその使用方法
|
US10806396B2
(en)
|
2015-01-26 |
2020-10-20 |
Alcyone Lifesciences, Inc. |
Drug delivery methods with tracer
|
AU2016235424A1
(en)
|
2015-03-20 |
2017-10-05 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles and uses thereof
|
JP6861166B2
(ja)
|
2015-03-27 |
2021-04-21 |
ダナ−ファーバー キャンサー インスティテュート, インコーポレイテッド |
サイクリン依存性キナーゼの阻害剤
|
EP3277808A4
(de)
|
2015-03-30 |
2019-05-22 |
Greenlight Biosciences, Inc. |
Zellfreie herstellung von ribonukleinsäure
|
EP3288557A4
(de)
|
2015-04-27 |
2018-11-07 |
University of Florida Research Foundation, Inc. |
Metabolisch programmierte metallchelatoren und verwendungen davon
|
WO2016178591A2
(en)
|
2015-05-05 |
2016-11-10 |
Gene Predit, Sa |
Genetic markers and treatment of male obesity
|
HRP20230494T1
(hr)
|
2015-06-19 |
2023-08-04 |
Massachusetts Institute Of Technology |
Alkenil supstituirani 2,5-piperazindioni i njihova upotreba u pripravcima za isporuku sredstva subjektu ili stanici
|
WO2017004548A1
(en)
|
2015-07-01 |
2017-01-05 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
EP3347372A4
(de)
|
2015-09-10 |
2019-09-04 |
Aileron Therapeutics, Inc. |
Peptidomimetische makrocyclen als modulatoren von mcl-1
|
HRP20220156T1
(hr)
|
2015-09-17 |
2022-04-15 |
Modernatx, Inc. |
Spojevi i pripravci za unutarstaničnu isporuku terapeutskih sredstava
|
DK3350333T3
(da)
|
2015-09-17 |
2022-01-31 |
Modernatx Inc |
Polynukleotider, der indeholder en stabiliserende haleregion
|
EP3355882A1
(de)
|
2015-10-01 |
2018-08-08 |
Kythera Biopharmaceuticals, Inc. |
Zusammensetzungen mit einem statin zur verwendung in verfahren zur adipolyse
|
GB201518684D0
(en)
|
2015-10-21 |
2015-12-02 |
Glaxosmithkline Biolog Sa |
Vaccine
|
WO2017088066A1
(en)
*
|
2015-11-28 |
2017-06-01 |
Biopreme Medical Technologies Inc. |
Negative pressure injection device
|
DK3394030T3
(da)
|
2015-12-22 |
2022-03-28 |
Modernatx Inc |
Forbindelser og sammensætninger til intracellulær afgivelse af midler
|
CN108472019A
(zh)
|
2016-01-04 |
2018-08-31 |
亚克安娜生命科学有限公司 |
用于治疗中风的方法和装置
|
US10500351B2
(en)
*
|
2016-02-12 |
2019-12-10 |
Shawn Michael Michels |
Aid for subcutaneous tissue injection and process of effecting the injection with the aid
|
GB201603625D0
(en)
|
2016-03-02 |
2016-04-13 |
Glaxosmithkline Biolog Sa |
Novel influenza antigens
|
CN109195996A
(zh)
|
2016-03-08 |
2019-01-11 |
中央研究院 |
N-聚醣及其阵列的模组化合成方法
|
WO2017161116A1
(en)
|
2016-03-17 |
2017-09-21 |
Infinity Pharmaceuticals, Inc. |
Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as pi3k kinase inhibitors
|
WO2017167768A1
(en)
|
2016-03-28 |
2017-10-05 |
Glaxosmithkline Biologicals S.A. |
Novel vaccine composition
|
US10954541B2
(en)
|
2016-04-06 |
2021-03-23 |
Greenlight Biosciences, Inc. |
Cell-free production of ribonucleic acid
|
CN115746107A
(zh)
|
2016-06-03 |
2023-03-07 |
圣诺菲·帕斯图尔公司 |
经改造的流感血凝素多肽的修饰
|
WO2017214337A1
(en)
|
2016-06-07 |
2017-12-14 |
Massachusetts Institute Of Technology |
Drug delivery polymers and uses thereof
|
WO2017214269A1
(en)
|
2016-06-08 |
2017-12-14 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
JP2019525901A
(ja)
|
2016-06-14 |
2019-09-12 |
モデルナティエックス インコーポレイテッドModernaTX,Inc. |
脂質ナノ粒子の安定化製剤
|
GB201610599D0
(en)
|
2016-06-17 |
2016-08-03 |
Glaxosmithkline Biologicals Sa |
Immunogenic Composition
|
MX2019001341A
(es)
|
2016-08-05 |
2019-07-04 |
Sanofi Pasteur Inc |
Composicion de conjugado de polisacarido neumococico multivalente-proteina.
|
CN109862908B
(zh)
|
2016-08-05 |
2023-05-02 |
圣诺菲·帕斯图尔公司 |
多价肺炎球菌多糖-蛋白质缀合物组合物
|
CA3034057A1
(en)
|
2016-08-22 |
2018-03-01 |
CHO Pharma Inc. |
Antibodies, binding fragments, and methods of use
|
WO2018089540A1
(en)
|
2016-11-08 |
2018-05-17 |
Modernatx, Inc. |
Stabilized formulations of lipid nanoparticles
|
CN110198703A
(zh)
|
2016-11-21 |
2019-09-03 |
艾里奥治疗公司 |
大试剂的透皮递送
|
WO2018106738A1
(en)
|
2016-12-05 |
2018-06-14 |
Massachusetts Institute Of Technology |
Brush-arm star polymers, conjugates and particles, and uses thereof
|
US20200086065A1
(en)
*
|
2016-12-16 |
2020-03-19 |
Hoffmann-La Roche Inc. |
Spacer for a syringe
|
RS63953B1
(sr)
|
2017-03-15 |
2023-02-28 |
Modernatx Inc |
Jedinjenje i kompozicije za intracelularnu isporuku terapeutskih sredstava
|
JP7332478B2
(ja)
|
2017-03-15 |
2023-08-23 |
モデルナティエックス インコーポレイテッド |
脂質ナノ粒子製剤
|
US11555031B2
(en)
|
2017-03-20 |
2023-01-17 |
The Broad Institute, Inc. |
Compounds and methods for regulating insulin secretion
|
WO2018232120A1
(en)
|
2017-06-14 |
2018-12-20 |
Modernatx, Inc. |
Compounds and compositions for intracellular delivery of agents
|
EP3641828B1
(de)
|
2017-06-23 |
2023-11-22 |
Affinivax, Inc. |
Immunogene zusammensetzungen
|
WO2019013790A1
(en)
|
2017-07-12 |
2019-01-17 |
Curza Global, Llc |
ANTIMICROBIAL COMPOUNDS AND USES THEREOF
|
WO2019013789A1
(en)
|
2017-07-12 |
2019-01-17 |
Curza Global, Llc |
ANTIMICROBIAL COMPOUNDS
|
EP3675817A1
(de)
|
2017-08-31 |
2020-07-08 |
Modernatx, Inc. |
Verfahren zur herstellung von lipidnanopartikeln
|
CN111465701A
(zh)
|
2017-10-11 |
2020-07-28 |
绿光生物科技股份有限公司 |
用于三磷酸核苷和核糖核酸生成的方法和组合物
|
WO2019109079A1
(en)
|
2017-12-01 |
2019-06-06 |
North Carolina State University |
Fibrin particles and methods of making the same
|
GB201721582D0
(en)
|
2017-12-21 |
2018-02-07 |
Glaxosmithkline Biologicals Sa |
S aureus antigens and immunogenic compositions
|
GB201721576D0
(en)
|
2017-12-21 |
2018-02-07 |
Glaxosmithkline Biologicals Sa |
Hla antigens and glycoconjugates thereof
|
CA3112549A1
(en)
|
2018-09-13 |
2020-03-19 |
Eirion Therapeutics, Inc. |
Uses of plasminogen activator inhibitor 1 (pai-1) inhibitors
|
SG11202102478SA
(en)
|
2018-09-13 |
2021-04-29 |
Eirion Therapeutics Inc |
Plasminogen activator inhibitor 1 (pai-1) inhibitors and uses therefor
|
US20220409536A1
(en)
|
2018-09-19 |
2022-12-29 |
Modernatx, Inc. |
Compounds and compositions for intracellular delivery of therapeutic agents
|
CA3113651A1
(en)
|
2018-09-20 |
2020-03-26 |
Modernatx, Inc. |
Preparation of lipid nanoparticles and methods of administration thereof
|
CA3119043A1
(en)
|
2018-12-03 |
2020-06-11 |
Eirion Therapeutics, Inc. |
Improved delivery of large agents
|
US20230072397A1
(en)
|
2019-01-16 |
2023-03-09 |
Curza Global, Llc |
Antimicrobial Compounds and Methods
|
US20230159491A1
(en)
|
2019-01-16 |
2023-05-25 |
Curza Global, Llc |
Antimicrobial Compounds and Methods
|
JP2022519557A
(ja)
|
2019-01-31 |
2022-03-24 |
モデルナティエックス インコーポレイテッド |
脂質ナノ粒子の調製方法
|
WO2020168466A1
(en)
|
2019-02-19 |
2020-08-27 |
Stemirna Therapeutics Co., Ltd. |
Modified nucleoside and synthetic methods thereof
|
CN110101944A
(zh)
*
|
2019-05-13 |
2019-08-09 |
马飒飒 |
一种神经阻滞麻醉针定位装置
|
KR20220008311A
(ko)
|
2019-05-14 |
2022-01-20 |
에이리온 테라퓨틱스, 인코포레이티드 |
최대 효과 지연 및/또는 반응 지속시간 연장
|
US20220265803A1
(en)
|
2019-07-31 |
2022-08-25 |
Sanofi Pasteur Inc. |
Multivalent pneumococcal polysaccharide-protein conjugate compositions and methods of using the same
|
AU2020319876A1
(en)
|
2019-07-31 |
2022-02-24 |
Modernatx, Inc. |
Compositions and methods for delivery of RNA interference agents to immune cells
|
WO2021097061A1
(en)
|
2019-11-13 |
2021-05-20 |
Curza Global, Llc |
Antimicrobial compounds and methods
|
WO2021155274A1
(en)
|
2020-01-31 |
2021-08-05 |
Modernatx, Inc. |
Methods of preparing lipid nanoparticles
|
WO2021173965A1
(en)
|
2020-02-28 |
2021-09-02 |
Massachusetts Institute Of Technology |
Identification of variable influenza residues and uses thereof
|
WO2021231729A1
(en)
|
2020-05-13 |
2021-11-18 |
Sanofi |
Adjuvanted stabilized stem hemagglutinin nanoparticles and methods of using the same to induce broadly neutralizing antibodies against influenza
|
CN116710116A
(zh)
|
2020-10-30 |
2023-09-05 |
Xeno-Interface株式会社 |
β折叠股桥肽
|
CN117083065A
(zh)
|
2020-10-30 |
2023-11-17 |
庆应义塾 |
肌肉减少症相关疾病等的新颖治疗和预防
|
TW202237068A
(zh)
|
2020-12-09 |
2022-10-01 |
美商建南德克公司 |
製備脂質奈米顆粒的高通量方法及其用途
|
EP4305088A1
(de)
|
2021-03-09 |
2024-01-17 |
Massachusetts Institute of Technology |
Verzweigte poly(aminoester) zur verabreichung von nukleinsäuren
|
TW202313065A
(zh)
|
2021-05-28 |
2023-04-01 |
美商季卡尼醫療公司 |
用於治療遺傳疾病之化合物
|
WO2023274860A1
(en)
|
2021-06-28 |
2023-01-05 |
Glaxosmithkline Biologicals Sa |
Novel influenza antigens
|
IT202100020528A1
(it)
|
2021-07-30 |
2023-01-30 |
Fiderm Srl |
Dispositivo di regolazione della profondità di penetrazione di un ago per siringhe e siringa includente detto dispositivo
|
WO2023018817A1
(en)
|
2021-08-11 |
2023-02-16 |
Sanofi Pasteur Inc. |
Truncated influenza neuraminidase and methods of using the same
|
US20230233667A1
(en)
|
2021-09-08 |
2023-07-27 |
Affinivax, Inc. |
Coronavirus vaccine
|
WO2023059857A1
(en)
|
2021-10-08 |
2023-04-13 |
Sanofi Pasteur Inc. |
Multivalent influenza vaccines
|
WO2023081798A1
(en)
|
2021-11-05 |
2023-05-11 |
Sanofi Pasteur Inc. |
Multivalent influenza vaccines comprising recombinant hemagglutinin and neuraminidase and methods of using the same
|
WO2023079113A1
(en)
|
2021-11-05 |
2023-05-11 |
Sanofi |
Hybrid multivalent influenza vaccines comprising hemagglutinin and neuraminidase and methods of using the same
|
WO2023114889A1
(en)
|
2021-12-16 |
2023-06-22 |
Modernatx, Inc. |
Processes for preparing lipid nanoparticles
|
WO2023129963A1
(en)
|
2021-12-30 |
2023-07-06 |
Curza Global, Llc |
Antimicrobial compounds and methods
|
WO2023144206A1
(en)
|
2022-01-27 |
2023-08-03 |
Sanofi Pasteur |
Modified vero cells and methods of using the same for virus production
|
WO2023177577A1
(en)
|
2022-03-14 |
2023-09-21 |
Sanofi Pasteur Inc. |
Machine-learning techniques in protein design for vaccine generation
|
WO2023193002A1
(en)
|
2022-04-01 |
2023-10-05 |
Modernatx, Inc. |
Cross mixers for lipid nanoparticle production, and methods of operating the same
|
WO2023235380A1
(en)
|
2022-06-01 |
2023-12-07 |
Zikani Therapeutics, Inc. |
Macrolides for treating genetic diseases
|
WO2023250513A1
(en)
|
2022-06-24 |
2023-12-28 |
Zikani Therapeutics, Inc. |
13-membered macrolide compounds for treating diseases mediated by abnormal protein translation
|
WO2024026475A1
(en)
|
2022-07-29 |
2024-02-01 |
Modernatx, Inc. |
Compositions for delivery to hematopoietic stem and progenitor cells (hspcs) and related uses
|
WO2024026487A1
(en)
|
2022-07-29 |
2024-02-01 |
Modernatx, Inc. |
Lipid nanoparticle compositions comprising phospholipid derivatives and related uses
|
WO2024026482A1
(en)
|
2022-07-29 |
2024-02-01 |
Modernatx, Inc. |
Lipid nanoparticle compositions comprising surface lipid derivatives and related uses
|
WO2024049994A1
(en)
|
2022-09-01 |
2024-03-07 |
Zikani Therapeutics, Inc. |
Treatment of familial adenomatous polyopsis using a 13-membered macrolide
|